Dietary α-eleostearic acid ameliorates experimental inflammatory bowel disease in mice by activating peroxisome proliferator-activated receptor-γ.
<h4>Background</h4>Treatments for inflammatory bowel disease (IBD) are modestly effective and associated with side effects from prolonged use. As there is no known cure for IBD, alternative therapeutic options are needed. Peroxisome proliferator-activated receptor-gamma (PPARγ) has been...
Guardado en:
Autores principales: | Stephanie N Lewis, Lera Brannan, Amir J Guri, Pinyi Lu, Raquel Hontecillas, Josep Bassaganya-Riera, David R Bevan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/996adb1b59ca44dd899616e84480526d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
First-in-class topical therapeutic omilancor ameliorates disease severity and inflammation through activation of LANCL2 pathway in psoriasis
por: Nuria Tubau-Juni, et al.
Publicado: (2021) -
Rosiglitazone-induced mitochondrial biogenesis in white adipose tissue is independent of peroxisome proliferator-activated receptor γ coactivator-1α.
por: Rosario Pardo, et al.
Publicado: (2011) -
Lysophosphatidic acid activates peroxisome proliferator activated receptor-γ in CHO cells that over-express glycerol 3-phosphate acyltransferase-1.
por: Cliona M Stapleton, et al.
Publicado: (2011) -
Epigenetic silencing of peroxisome proliferator-activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome.
por: Massimo Pancione, et al.
Publicado: (2010) -
Acetate rescues defective brain-adipose metabolic network in obese Wistar rats by modulation of peroxisome proliferator-activated receptor-γ
por: Kehinde Samuel Olaniyi, et al.
Publicado: (2021)